“Dishman holds a license agreement from Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical companies of J&J to produce active pharmaceutical ingredient (API) of Sirturo (bedaquiline),” the pharma company said in its regulatory filing to exchanges.
| Subscribe To Our Free Newsletter |
